Medical Science Liaison, Abbott Point of Care (APOC)
Abbott- Full Time
- Entry Level & New Grad
Dianthus Therapeutics is a publicly traded, clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who are leading the development of next-generation antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases. To learn more, please visit www.dianthustx.com and follow us on LinkedIn.
This role, the Regional Head of Medical and Clinical Affairs, will lead and oversee the company’s medical affairs strategy and activities across the APAC region. Reporting to the Global Head of Medical Affairs, you will be responsible for driving medical excellence, supporting clinical development, ensuring scientific communication, and fostering relationships with key opinion leaders (KOLs), healthcare professionals (HCPs), and patient advocacy groups. You will play a crucial role in shaping the company's growth in the APAC market and ensuring alignment with regulatory and healthcare organizations. Experience in clinical development and medical affairs is ideal to support Phase II/III programs through commercialization. This is a unique opportunity to join an effort to bring a best in class complement inhibitor to patients in need, and to build Dianthus presence and capabilities in the region. We are building a culture of individuals who hold our core principles at the center of our operations, with the goal to elevate the care of our patients’ lives. We are open to you working remotely.
Develops therapies for autoimmune diseases
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.